DOAJ Open Access 2025

BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients

Fernando Pérez-Calvo Francisco Jover-Diaz Elisabet Delgado-Sánchez Jorge Peris-García María Ángeles Bernabéu-Martínez

Lihat Sumber DOI

Topik & Kata Kunci

Immunologic diseases. Allergy

Penulis (5)

Fernando Pérez-Calvo

Francisco Jover-Diaz

Elisabet Delgado-Sánchez

Jorge Peris-García

María Ángeles Bernabéu-Martínez

Format Sitasi

APA MLA BibTeX

Pérez-Calvo, F., Jover-Diaz, F., Delgado-Sánchez, E., Peris-García, J., Bernabéu-Martínez, M.Á. (2025). BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients. https://doi.org/10.1155/arat/8818830

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.1155/arat/8818830

Informasi Jurnal

Tahun Terbit: 2025
Sumber Database: DOAJ
DOI: 10.1155/arat/8818830
Akses: Open Access ✓